10x Genomics, Inc. Class A Common Stock TXG
$58.15
+0.69%
at last close
Analyst Consensus
- Consensus Rating
- Hold (5 Buy · 8 Hold · 0 Sell)
- Average Price Target
- $38.00
- Implied Upside
- -34.7%
- Price Target Range
- $19.00 – $65.00
- Analysts (12 mo)
- 13
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-12 | Stephens & Co.Mason Carrico |
Maintains | Overweight | $50 → $65 |
| 2026-08-10 | Piper SandlerDavid Westenberg |
Maintains | Neutral | $42 → $47 |
| 2026-08-10 | Canaccord GenuityKyle Mikson |
Maintains | Buy | $50 → $60 |
| 2026-08-07 | CitigroupBrendan Digan |
Maintains | Neutral | $45 → $50 |
| 2026-08-07 | Morgan StanleyTejas Savant |
Maintains | Equal-weight | $37 → $40 |
| 2026-07-17 | Leerink PartnersMike Kratky |
Maintains | Market perform | $23 → $40 |
| 2026-07-14 | Canaccord GenuityKyle Mikson |
Maintains | Buy | $32 → $50 |
| 2026-07-09 | Morgan StanleyTejas Savant |
Maintains | Equal-weight | $22 → $37 |
| 2026-07-08 | CitigroupPatrick Donnelly |
Maintains | Neutral | $24 → $45 |
| 2026-07-01 | Piper SandlerDavid Westenberg |
Maintains | Neutral | $20 → $42 |
| 2026-06-24 | BarclaysLuke Sergott |
Maintains | Overweight | $30 → $40 |
| 2026-05-12 | Morgan StanleyTejas Savant |
Maintains | Equal-weight | $20 → $22 |
| 2026-05-12 | JP MorganCasey Woodring |
Maintains | Neutral | $17 → $20 |
| 2026-04-20 | Canaccord GenuityKyle Mikson |
Maintains | Buy | $22 → $32 |
| 2026-04-20 | B of A SecuritiesDerik De Bruin |
Maintains | Neutral | $21 → $30 |
| 2026-04-14 | BarclaysLuke Sergott |
Maintains | Overweight | $22 → $30 |
| 2026-04-07 | CitigroupPatrick Donnelly |
Maintains | Neutral | $18 → $24 |
| 2026-03-31 | William BlairMatt Larew |
Upgrades | Market perform → Outperform | — |
| 2026-03-02 | StifelDaniel Arias |
Maintains | Buy | $20 → $25 |
| 2026-02-20 | UBSDan Leonard |
Maintains | Neutral | $14 → $20 |
| 2026-02-13 | StifelDaniel Arias |
Maintains | Buy | $15 → $20 |
| 2026-02-13 | TD CowenDan Brennan |
Maintains | Hold | $18 → $19 |
| 2026-01-27 | Leerink PartnersMike Kratky |
Maintains | Market perform | $22 → $20 |
| 2026-01-16 | Leerink PartnersMike Kratky |
Maintains | Market perform | $20 → $22 |
| 2026-01-07 | Leerink PartnersMike Kratky |
Maintains | Market perform | $15 → $20 |
| 2026-01-07 | TD CowenDan Brennan |
Maintains | Hold | $15 → $18 |
| 2025-12-22 | Canaccord GenuityKyle Mikson |
Maintains | Buy | $19 → $20 |
| 2025-12-15 | BarclaysLuke Sergott |
Maintains | Overweight | $17 → $22 |
| 2025-12-11 | CitigroupPatrick Donnelly |
Downgrades | Buy → Neutral | $18 |
| 2025-12-02 | Morgan StanleyTejas Savant |
Downgrades | Overweight → Equal-weight | $17 → $20 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $58.15
- Market Cap
- $7.52 billion
- 52-Week Range
- $11.16 – $60.69
- Average Volume
- 3.13 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.